Homocysteine, folate and vitamin b12 in Colombian patients with coronary disease

被引:0
作者
Garcia, Gilberto [1 ]
Trejos, Juanita [1 ]
Restrepo, Beatriz [1 ]
Landazuri, Patricia [1 ]
机构
[1] Univ Quindio, Fac Ciencias Salud, Quindio, Colombia
关键词
homocysteine; folate; vitamin B12; coronary disease; lipids; pteroypolyglutamic acids;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the occurrence of association between homocysteine, folate, or vitamin B12 plasma levels and acute coronary syndrome in Colombian patients. Methods: Case control study: cases were 50 patients with acute coronary syndrome and controls were 50 outpatients without coronary syndrome. Homocysteine, folate and vitamin B12 levels were determined by means of chemiluminescence immunoassay Cholesterol and lipoproteins, triglycerides, BUN, creatinine, hemoglobin and hematocrit were also measured. Results: Mean homocysteine plasma concentrations were significantly different between cases (12.4 mu mol/l +/- 6.0) and controls (9.7 1-mu mol/l +/- 2.4), p=0.01. The folic acid levels of the cases were lower than those of the control patients (10.5 ng/ml +/- 3.5 vs 12.6 ng/ml 3.6, respectively, P=0.01). An inverse relationship was found between folate and homocysteine levels. No relationship was observed between vitamin B12 levels and homocysteine levels. There was a significant difference in triglyceride levels between case and control groups (136.91 +/- 67.27 vs 174.3 +/- 77.6, respectively, p=0.01). The odds ratio for hyperhomocysteinemia in acute coronary syndrome was 4.45 (95% confidence interval: 1.5 - 13.3). Conclusion: The present study found a significant association between homocysteine levels and acute coronary syndrome in Colombian patients, similarly to the European and North American populations. There was a negative correlation between homocysteine plasma levels and folate levels. No association between plasmatic levels of homocysteine and those of vitamin B12 was observed.
引用
收藏
页码:79 / 85
页数:7
相关论文
共 32 条
  • [1] AGUDELO LE, 1986, GENESIS PUEBLO ANTIO
  • [2] ARCOSBURGOS M, 1992, EVALUACION EPIDEMIOL
  • [3] BERMUDEZ M, 2006, REV COLOMBIANA MED, V37, P46
  • [4] Bleie O, 2004, AM J CLIN NUTR, V80, P641
  • [5] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES
    BOUSHEY, CJ
    BERESFORD, SAA
    OMENN, GS
    MOTULSKY, AG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13): : 1049 - 1057
  • [6] Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease -: The result of a meta-analysis
    Brattström, L
    Wilcken, DEL
    Öhrvik, J
    Brudin, L
    [J]. CIRCULATION, 1998, 98 (23) : 2520 - 2526
  • [7] Bravo ML, 1996, GENE GEOGR, V10, P11
  • [8] Homocysteine: a novel risk factor for coronary heart disease in UK Indian Asians
    Chambers, JC
    Kooner, JS
    [J]. HEART, 2001, 86 (02) : 121 - 122
  • [9] *DANE, 2001, DEF TOT POR SEX 20 P
  • [10] Endothelial nitric oxide synthase-786T>C, but not 894G>T and 4a4b, polymorphism influences plasma homocysteine concentrations in persons with normal vitamin status
    Fatini, C
    Sofi, F
    Gori, AM
    Sticchi, E
    Marcucci, R
    Lenti, M
    Casini, A
    Surrenti, C
    Abbate, R
    Gensini, GF
    [J]. CLINICAL CHEMISTRY, 2005, 51 (07) : 1159 - 1164